David E. Lazar 13D and 13G filings for NovaBay Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-17 5:29 pm Purchase | 2025-10-16 | 13D | NovaBay Pharmaceuticals, Inc. NBY | David E. Lazar | 1,502,080 19.990% | 302,032 (+25.17%) | Filing |
| 2025-08-26 4:11 pm Purchase | 2025-08-19 | 13D | NovaBay Pharmaceuticals, Inc. NBY | David E. Lazar | 1,200,048 19.990% | 1,200,048 (New Position) | Filing |